Clinical Trial

AI Assessment of Low-Gradient Aortic Stenosis Severity Based on Echocardiography

Study acronym: ASAI-POL
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the effectiveness of an artificial intelligence (AI) model developed by the investigators for identifying severe low-gradient aortic valve stenosis. Accurate assessment of stenosis severity is crucial for proper qualification for surgical treatment. It is expected that the use of AI will improve diagnostic accuracy and thereby support better clinical outcomes. Patients with suspected significant low-gradient aortic stenosis will be enrolled. The study is observational and involves no additional risk for participants. Standard imaging studies performed for clinical indications will be additionally analyzed by the AI model, which will classify aortic stenosis as severe or moderate. The model's results will not influence the clinical management of participants but will be compared with physicians' assessments to validate its diagnostic performance. The study will be conducted in 2025-2026. The findings will provide insights into the usefulness of AI in the diagnosis of severe aortic stenosis and may contribute to the development of advanced clinical decision-support tools.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-20.
Status change: Not Yet Recruiting → Recruiting 2025-11-24
Trial Details
NCT Number NCT07144189
Lead Sponsor National Institute of Cardiology, Warsaw, Poland
Collaborators: The Institute of Bioorganic Chemistry, Polish Academy of Sciences
Conditions Low-gradient Aortic Stenosis, Aortic Stenosis
Enrollment 300 participants
Start Date 2025-08-20
Primary Completion 2026-08-20 (estimated)
Study Completion 2026-08-20 (estimated)
Updated on ClinicalTrials.gov 2025-12-02